{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:53Z","timestamp":1792787993035,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"james gilliam distinguished chair in dermatology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Morphea is an autoimmune, sclerosing skin disorder. Despite the recent emphasis on immune dysregulation in morphea, the role of autoantibodies in morphea pathogenesis or utility as biomarkers are poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Autoantigen microarray was used to profile autoantibodies from the serum of participants from the Morphea in Adults and Children (MAC) cohort. Clinical and demographic features of morphea patients with myelin basic protein (MBP) autoantibodies were compared to those without. MBP immunohistochemistry staining was subsequently performed in morphea skin to assess for perineural inflammation in areas of staining. Immunofluorescence staining on mouse brain tissue was also performed using patient sera and mouse anti-myelin basic protein antibody to confirm the presence of MBP antibodies in patient sera.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Myelin basic protein autoantibodies were found in greater frequency in morphea (n\u2009=\u200950, 71.4%) compared to systemic sclerosis (n\u2009=\u20092, 6.7%) and healthy controls (n\u2009=\u20097, 20%). Patients with MBP antibodies reported pain at higher frequencies. Morphea skin biopsies, highlighted by immunohistochemistry, demonstrated increased perineural inflammation in areas of MBP expression. Immunofluorescence staining revealed an increased fluorescence signal in myelinated areas of mouse brain tissue (i.e. axons) when incubated with sera from MBP antibody-positive morphea patients compared to sera from MBP antibody-negative morphea patients. Epitope mapping revealed target epitopes for MBP autoantibodies in morphea are distinct from those reported in MS, and included fragments 11\u201330, 41\u201360, 51\u201370, and\u00a091\u2013110.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A molecular classification of morphea based on distinct autoantibody biosignatures may be used to differentially classify morphea. We have identified anti-MBP as a potential antibody associated with morphea due to its increased expression in morphea compared to healthy controls and systemic sclerosis patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-022-03246-5","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T08:10:05Z","timestamp":1643011805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea"],"prefix":"10.1186","volume":"20","author":[{"given":"Jane L.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo T.","family":"Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Florez-Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kunzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Teske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniya Byekova","family":"Rainwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Hosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M. O.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Monson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5205-990X","authenticated-orcid":false,"given":"Heidi T.","family":"Jacobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"3246_CR1","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/art.38853","volume":"66","author":"D Condie","year":"2014","unstructured":"Condie D, Grabell D, Jacobe H. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort. Arthritis Rheumatol. 2014;66:3496\u2013504.","journal-title":"Arthritis Rheumatol"},{"key":"3246_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","volume":"145","author":"JJ Leitenberger","year":"2009","unstructured":"Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol. 2009;145:545\u201350.","journal-title":"Arch Dermatol"},{"key":"3246_CR3","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukamel M, Vesely RJA. Rheumatism: localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873\u201381.","journal-title":"Arthritis Rheum"},{"key":"3246_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","volume":"149","author":"JW Dharamsi","year":"2013","unstructured":"Dharamsi JW, Victor S, Aguwa N, Ahn C, Arnett F, Mayes MD, Jacobe H. Morphea in adults and children cohort III: nested case-control study: the clinical significance of autoantibodies in morphea. JAMA Dermatol. 2013;149:1159\u201365.","journal-title":"JAMA Dermatol"},{"key":"3246_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jaad.2016.12.020","volume":"76","author":"D Walker","year":"2017","unstructured":"Walker D, Susa JS, Currimbhoy S, Jacobe H. Histopathological changes in morphea and their clinical correlates: results from the Morphea in Adults and Children Cohort V. J Am Acad Dermatol. 2017;76:1124\u201330.","journal-title":"J Am Acad Dermatol"},{"key":"3246_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest. 1996;98:785\u201392.","journal-title":"J Clin Invest"},{"key":"3246_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","volume":"52","author":"S Tomimura","year":"2008","unstructured":"Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci. 2008;52:47\u201354.","journal-title":"J Dermatol Sci"},{"key":"3246_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/rheumatology\/40.6.683","volume":"40","author":"K Yamane","year":"2001","unstructured":"Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Antibodies to Th\/To ribonucleoprotein in patients with localized scleroderma. Rheumatology (Oxford). 2001;40:683\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"3246_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/ard.60.12.1157","volume":"60","author":"K Yimane","year":"2001","unstructured":"Yimane K, Ihn H, Kubo M, Asano Y, Yazawa N, Tamaki K. Anti-U3 snRNP antibodies in localised scleroderma. Ann Rheum Dis. 2001;60:1157\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3246_CR10","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.080098","volume":"35","author":"T Arkachaisri","year":"2008","unstructured":"Arkachaisri T, Fertig N, Pino S, Medsger TA Jr. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. J Rheumatol. 2008;35:2439\u201344.","journal-title":"J Rheumatol"},{"key":"3246_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/art.11432","volume":"50","author":"I Hayakawa","year":"2004","unstructured":"Hayakawa I, Hasegawa M, Takehara K, Sato S. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Arthritis Rheum. 2004;50:227\u201332.","journal-title":"Arthritis Rheum"},{"key":"3246_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1529-8019.2012.01479.x","volume":"25","author":"A Kreuter","year":"2012","unstructured":"Kreuter A. Localized scleroderma. Dermatol Ther. 2012;25:135\u201347.","journal-title":"Dermatol Ther"},{"key":"3246_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/art.1780360815","volume":"36","author":"S Sato","year":"1993","unstructured":"Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum. 1993;36:1137\u201341.","journal-title":"Arthritis Rheum"},{"key":"3246_CR14","doi-asserted-by":"publisher","first-page":"e26061","DOI":"10.1371\/journal.pone.0026061","volume":"6","author":"S Assassi","year":"2011","unstructured":"Assassi S, Leyva AL, Mayes MD, Sharif R, Nair DK, Fischbach M, Nguyen N, Reveille JD, Gonzalez EB, McNearney TA, Group GS. Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. PLoS ONE. 2011;6:e26061.","journal-title":"PLoS ONE"},{"key":"3246_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/ard.2009.111906","volume":"69","author":"FC Arnett","year":"2010","unstructured":"Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, Tan FK, McNearney T, Fischbach M, Fritzler MJ, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010;69:822\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3246_CR16","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri T, Vilaiyuk S, Li S, O\u2019Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, et al. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009;36:2819\u201329.","journal-title":"J Rheumatol"},{"key":"3246_CR17","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/ar3927","volume":"14","author":"NJ Olsen","year":"2012","unstructured":"Olsen NJ, Li Q-Z, Quan J, Wang L, Mutwally A, Karp DR. Autoantibody profiling to follow evolution of lupus syndromes. Arthritis Res Ther. 2012;14:R174.","journal-title":"Arthritis Res Ther"},{"key":"3246_CR18","first-page":"1","volume":"13","author":"Q-Z Li","year":"2011","unstructured":"Li Q-Z, Karp DR, Quan J, Branch VK, Zhou J, Lian Y, Chong BF, Wakeland EK, Olsen NJ. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther. 2011;13:1\u201311.","journal-title":"Arthritis Res Ther"},{"key":"3246_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1365-2133.2000.03886.x","volume":"143","author":"TK Gilmour","year":"2000","unstructured":"Gilmour TK, Wilkinson B, Breit SN, Kossard S. Analysis of dendritic cell populations using a revised histological staging of morphoea. Br J Dermatol. 2000;143:1183\u201392.","journal-title":"Br J Dermatol"},{"key":"3246_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cup.12242","volume":"41","author":"CA Dhaliwal","year":"2014","unstructured":"Dhaliwal CA, MacKenzie AI, Biswas A. Perineural inflammation in morphea (localized scleroderma): systematic characterization of a poorly recognized but potentially useful histopathological feature. J Cutan Pathol. 2014;41:28\u201335.","journal-title":"J Cutan Pathol"},{"key":"3246_CR21","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1111\/j.1468-3083.2012.04581.x","volume":"27","author":"F Succaria","year":"2013","unstructured":"Succaria F, Kurban M, Kibbi AG, Abbas O. Clinicopathological study of 81 cases of localized and systemic scleroderma. J Eur Acad Dermatol Venereol. 2013;27:e191-196.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3246_CR22","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3246_CR23","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1172\/JCI70231","volume":"123","author":"JV Price","year":"2013","unstructured":"Price JV, Haddon DJ, Kemmer D, Delepine G, Mandelbaum G, Jarrell JA, Gupta R, Balboni I, Chakravarty EF, Sokolove J, et al. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest. 2013;123:5135\u201345.","journal-title":"J Clin Invest"},{"key":"3246_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2209\/tdcpublication.56.105","volume":"56","author":"K Yoshida","year":"2015","unstructured":"Yoshida K, Sato K, Tonogi M, Tanaka Y, Yamane GY, Katakura A. Expression of cytokeratin 14 and 19 in process of oral carcinogenesis. Bull Tokyo Dent Coll. 2015;56:105\u201311.","journal-title":"Bull Tokyo Dent Coll"},{"key":"3246_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.onc.1209802","volume":"26","author":"YJ Chen","year":"2007","unstructured":"Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene. 2007;26:467\u201376.","journal-title":"Oncogene"},{"key":"3246_CR26","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/ar3763","volume":"14","author":"M Hudson","year":"2012","unstructured":"Hudson M, Pope J, Mahler M, Tatibouet S, Steele R, Baron M, Fritzler MJ. Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis. Arthritis Res Ther. 2012;14:R50.","journal-title":"Arthritis Res Ther"},{"key":"3246_CR27","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1038\/jid.2012.207","volume":"132","author":"BF Chong","year":"2012","unstructured":"Chong BF, Tseng LC, Lee T, Vasquez R, Li QZ, Zhang S, Karp DR, Olsen NJ, Mohan C. IgG and IgM autoantibody differences in discoid and systemic lupus patients. J Invest Dermatol. 2012;132:2770\u20139.","journal-title":"J Invest Dermatol"},{"key":"3246_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1155\/2014\/925805","volume":"2014","author":"RB Thorpe","year":"2014","unstructured":"Thorpe RB, Gray A, Kumar KR, Susa JS, Chong BF. Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin. Scientific World Journal. 2014;2014:12.","journal-title":"Scientific World Journal"},{"key":"3246_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0165-5728(94)90191-0","volume":"49","author":"K Gerritse","year":"1994","unstructured":"Gerritse K, Deen C, Fasbender M, Ravid R, Boersma W, Claassen E. The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J Neuroimmunol. 1994;49:153\u20139.","journal-title":"J Neuroimmunol"},{"key":"3246_CR30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.4049\/jimmunol.180.2.1258","volume":"180","author":"AA Belogurov","year":"2008","unstructured":"Belogurov AA, Kurkova IN, Friboulet A, Thomas D, Misikov VK, Zakharova MY, Suchkov SV, Kotov SV, Alehin AI, Avalle B, et al. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol. 2008;180:1258\u201367.","journal-title":"J Immunol"},{"key":"3246_CR31","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1177\/1352458513485653","volume":"19","author":"K Van Haren","year":"2013","unstructured":"Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T, Tenembaum SN, Pohl D, Rostasy K, Dale RC, et al. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Mult Scler. 2013;19:1726\u201333.","journal-title":"Mult Scler"},{"key":"3246_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","volume":"52","author":"S Tomimura","year":"2008","unstructured":"Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci. 2008;52:47\u201354.","journal-title":"J Dermatol Sci"},{"key":"3246_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1073\/pnas.0509849103","volume":"103","author":"NA Ponomarenko","year":"2006","unstructured":"Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA Jr, Kurkova IN, Petrenko AG, Telegin GB, Suchkov SV, Kiselev SL, Lagarkova MA, et al. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci USA. 2006;103:281\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3246_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1742-2094-9-119","volume":"9","author":"H Liu","year":"2012","unstructured":"Liu H, Shiryaev SA, Chernov AV, Kim Y, Shubayev I, Remacle AG, Baranovskaya S, Golubkov VS, Strongin AY, Shubayev VI. Immunodominant fragments of myelin basic protein initiate T cell-dependent pain. J Neuroinflamm. 2012;9:119.","journal-title":"J Neuroinflamm"},{"key":"3246_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00221-009-1724-6","volume":"196","author":"M Devor","year":"2009","unstructured":"Devor M. Ectopic discharge in Abeta afferents as a source of neuropathic pain. Exp Brain Res. 2009;196:115\u201328.","journal-title":"Exp Brain Res"},{"key":"3246_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.bbi.2006.07.007","volume":"21","author":"G Moalem-Taylor","year":"2007","unstructured":"Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Brain Behav Immun. 2007;21:699\u2013710.","journal-title":"Brain Behav Immun"},{"key":"3246_CR37","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/bjd.13572","volume":"172","author":"N Klimas","year":"2015","unstructured":"Klimas N, Shedd A, Bernstein I, Jacobe H. Health-related quality of life in morphoea. Br J Dermatol. 2015;172:1329\u201337.","journal-title":"Br J Dermatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03246-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03246-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03246-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T08:16:43Z","timestamp":1643012203000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03246-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03246-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at University of Texas Southwestern Medical Center, Dallas, TX. Each patient provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors state no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}